Security key
00773U108
Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share (ADVM)
CUSIP: 00773U108
Q1 2024 13F Holders as of 31 Mar 2024
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Total 13F shares
- 3,584,406
- Total 13F value
- $50,683,501
- Share change
- -60,548,064
- SEC-reported price per share
- $14.14
- Number of holders
- 3
- Value change
- -$65,439,463
- Number of buys
- 2
- Number of sells
- 58
- Shares outstanding
- 22,163,711
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2024
Institutions
3
Top holders
3
ADVM full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Adverum Biotechnologies, Inc. SEC filings
Adverum Biotechnologies, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 00773U108
Recent filing periods:
Ownership snapshot
Top reported holders of ADVM - Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Commodore Capital LP
Disclosed value leader
Commodore Capital LP
Comparable rows
15/15
Latest evidence
31 Dec 2023
13F
Lead comparable stake: 45%
Showing 1-6 of 15 holder rows.
Quick read
Commodore Capital LP leads the comparable SEC ownership view at 45%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Commodore Capital LP's linked filing trail.
Comparable ownership
Top 5
Commodore Capital LP
45%
FMR LLC
28%
MORGAN STANLEY
23%
Venrock Adviser, LLC
23%
Versant Venture Management, LLC
23%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Commodore Capital LP |
13F
Company
|
45%
|
$7,528,000
10,000,000 shares
|
— | 31 Dec 2023 |
| FMR LLC |
13F
Company
|
28%
|
$4,610,352
6,124,272 shares
|
— | 31 Dec 2023 |
| MORGAN STANLEY |
13F
Company
|
23%
|
$3,877,219
5,150,396 shares
|
— | 31 Dec 2023 |
| Venrock Adviser, LLC |
13F
Company
|
23%
|
$3,875,073
5,147,547 shares
|
— | 31 Dec 2023 |
| Versant Venture Management, LLC |
13F
Company
|
23%
|
$3,815,366
5,068,233 shares
|
— | 31 Dec 2023 |
| BML Capital Management, LLC |
13F
Company
|
21%
|
$3,428,441
4,554,252 shares
|
— | 31 Dec 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
3
Shares
3,584,406
Rows available
3
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2024 vs Q3 2025 Across Filers
Q3 2025 holders
1
Q1 2024 holders
3
Holder diff
2
| Investor | Q3 2025 Shares | Q1 2024 Shares | Share Diff | Share Chg % | Q3 2025 value | Q1 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend